Skip to main content

Simvastatin (International)

In the US, Simvastatin (simvastatin systemic) is a member of the drug class statins and is used to treat Cardiovascular Risk Reduction, High Cholesterol, High Cholesterol - Familial Heterozygous, High Cholesterol - Familial Homozygous, Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa - Elevated LDL, Hyperlipoproteinemia Type IIb - Elevated LDL VLDL, Hyperlipoproteinemia Type III - Elevated beta-VLDL IDL, Hyperlipoproteinemia Type IV - Elevated VLDL and Prevention of Cardiovascular Disease.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C10AA01

CAS registry number (Chemical Abstracts Service)

0079902-63-9

Chemical Formula

C25-H38-O5

Molecular Weight

419

Therapeutic Category

Lipidemic agent: HMG CoA reductase inhibitor (statin)

Chemical Name

Butanoic acid, 2,2-dimetyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimetyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-etyl]-1-naphtalenyl ester

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.